HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.

AuthorsK Y Ho, G A Smythe, L Lazarus
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 56 Issue 4 Pg. 692-6 (Apr 1983) ISSN: 0021-972X [Print] United States
PMID6833458 (Publication Type: Journal Article)
Chemical References
  • Contraceptives, Oral
  • Contraceptives, Oral, Combined
  • Dopamine Antagonists
  • Prolactin
  • Monoiodotyrosine
  • Dopamine
Topics
  • Adolescent
  • Adult
  • Contraceptives, Oral (adverse effects)
  • Contraceptives, Oral, Combined (adverse effects)
  • Dopamine (physiology)
  • Dopamine Antagonists
  • Female
  • Humans
  • Monoiodotyrosine
  • Pituitary Neoplasms (metabolism)
  • Prolactin (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: